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Aim
To evaluate whole body diffusion-weighted MR imaging
(WB-DWI MRI) for detection, staging and operability
assessment in recurrent ovarian cancer compared
with CT.
Methods
Fifty-one women suspected for recurrent ovarian cancer
underwent 3-Tesla WB-DWI/MRI using 2 b-values
(b=0-1000 s/mm²), T2- and contrast T1-weighted
sequences in addition to CT. WB-DWI/MRI and CT
were compared for per-patient detection of recurrence,
per-site detection of disease extent including peritoneal,
serosal, retroperitoneal, periportal and distant metastases
and for detecting disease extent according to institutional
operability criteria. Imaging findings were correlated with
surgical/pathological findings or imaging follow-up for at
least 6 months.
Results
According to the reference standard, recurrence was
confirmed in 48/51 patients. WB-DWI MRI showed
94% accuracy for detecting recurrence, versus 78% for
CT. Per-site analysis showed significantly higher sensi-
tivity of WB-DWI MRI over CT for assessing disease
extent of the peritoneum, small bowel and colon mesen-
tery and serosa (p<0.000001, p<0.000001 and p=0.00002,
respectively), retroperitoneal suprarenal lymphadenopa-
thies and periportal lesions (both p=0.031). Following
institutional operability criteria, WB-DWI/MRI showed
better sensitivity for detection of disease extent compro-
mising operability; mesenteric root infiltration (p=0.008),
carcinomatosis of small bowel (p=0.002) and colon
(p=0.016), high volumetric peritoneal disease load
(p=0.004) and irresectable distant metastases (p=0.016).
WB-DWI MRI correctly predicted complete cytoreduction
in 93% patients undergoing cytoreductive surgery versus
40% for CT.
Conclusion
WB-DWI MRI showed higher accuracy compared with
CT for recurrence detection while improving the sensitiv-
ity for staging and operability assessment of disease extent.
WB-DWI MRI may be most valuable to select patients for
surgical resection.
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